HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2226987Generated: October 31, 2026
Potassium Hydroxide → HCID 131718681, compound
https://huagongshe.com/reaction/2226987
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Potassium Hydroxide | HCID 14797 | — |
| Reactant | Clarithromycin | HCID 84029 | — |
| Reactant | 2-[2-(2-Ethoxyethoxy)ethoxy]ethyl carbonochloridate | HCID 18964125 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | Erythromycin | HCID 12560 | — |
| Product | HCID 131718681 | HCID 131718681 | 598.4% |
Reaction Steps
To a solution of 6-O-methylerythromycin A (10 g) in tetrahydrofuran (50 ml ), were added 95 % potassium hydroxide powder (0.87 g ) and 2 - [2 - (2 -ethoxyethoxy ) ethoxy ]ethyl chloroformate (3.60 g) under ice-cooling. After stirring for 3 hours, 95% potassium hydroxide powder (0.24 g ) and 2- [2-(2 -ethoxyethoxy ) ethoxy ]ethyl chloroformate (0.98 g ) were further added thereto and the mixture was stirred for additional 2 days. The post treatment was performed by the same method as the one described in Example 7. The crude product thus obtained was purified by silica gel column chromatography (elution solvent; acetone : n-hexane =7 : 13 - 2 : 3) and then crystallized from chloroform/n-hexane. Thus 6-0-methylerythromycin A 2 '- {2- [2- (2-ethoxyethoxy ) ethoxy]ethyl}carbonate (8.85 g) was obtained as a white powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05350839 |
|---|
| Source dataset | uspto-grants-1994_09 |
|---|
| ORD ID | ord-5cc3e8eaab8c41e4b3d99d11b62d7aca |
|---|
| Source note | uspto-grants-1994_09 |
|---|